Harry L.A. Janssen joined the Arbutus Scientific Advisory Board, while Anuj was appointed VP at Vertex. Janssen also maintains ties with Erasmus MC in Rotterdam.
2 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Harry L.A. Janssen joined the Arbutus Scientific Advisory Board, while Anuj was appointed VP at Vertex. Janssen also maintains ties with Erasmus MC in Rotterdam.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Harry L.A. Janssen
researcher 0000-0003-2398-8392
Nothing else this week.
-
Arbutus Biopharma
Canadian Bio Tech Company
-
Anuj
Indian businessperson (born 1987, child of Balvinder)
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireArbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to
- Unknown outlet